Cargando…
Pharmaceutical formulation : the science and technology of dosage forms /
Pharmaceutical Formulation provides an up to date source of information for all who wish to understand the principles and practice of formulation in the drug industry.
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Cambridge :
Royal Society of Chemistry,
2018
|
| Colección: | RSC drug discovery series ;
64. |
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | KNOVEL_on1042220679 | ||
| 003 | OCoLC | ||
| 005 | 20231027140348.0 | ||
| 006 | m o d | ||
| 007 | cr cnu|||unuuu | ||
| 008 | 180629s2018 enk o 001 0 eng d | ||
| 040 | |a UKRSC |b eng |e rda |e pn |c UKRSC |d MERER |d OCLCF |d OCLCQ |d N$T |d LVT |d EBLCP |d YDX |d COO |d OCLCO |d OCLCQ |d KNOVL |d OCLCQ |d OCLCA |d OCLCQ |d K6U |d OCLCQ |d OCLCO |d OCLCQ |d OCLCO |d OCLCQ |d OCLCO | ||
| 020 | |a 9781782620402 |q (electronic bk.) | ||
| 020 | |a 1782620400 |q (electronic bk.) | ||
| 020 | |a 9781523122899 |q (electronic bk.) | ||
| 020 | |a 1523122897 |q (electronic bk.) | ||
| 020 | |z 9781849739412 |q (print) | ||
| 029 | 1 | |a AU@ |b 000063566598 | |
| 035 | |a (OCoLC)1042220679 | ||
| 037 | |a 3501:3383 |b Royal Society of Chemistry |n http://www.rsc.org/spr | ||
| 050 | 4 | |a RS200 | |
| 060 | 4 | |a QV 786 | |
| 072 | 7 | |a MED |x 071000 |2 bisacsh | |
| 082 | 0 | 4 | |a 615.1/9 |2 23 |
| 049 | |a UAMI | ||
| 245 | 0 | 0 | |a Pharmaceutical formulation : |b the science and technology of dosage forms / |c editors: Geoffrey D. Tovey. |
| 264 | 1 | |a Cambridge : |b Royal Society of Chemistry, |c 2018 | |
| 300 | |a 1 online resource (409 pages) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a RSC drug discovery series ; |v 64 | |
| 500 | |a Includes index. | ||
| 500 | |a Title from title details screen. | ||
| 505 | 0 | |a Intro; Title Page; Copyright Page; Preface; Contents; Chapter 1 Preformulation Studies; 1.1 Introduction; 1.2 Solubility; 1.2.1 Absolute (Intrinsic) Solubility; 1.2.2 Molecular Dissociation pKa; 1.2.3 Solubility in Various Solvents; 1.2.4 Solubility Rate (Dissolution); 1.3 Diffusion; 1.4 Partition Coefficient; 1.5 Permeability; 1.6 The Biopharmaceutical Classification System; 1.7 Moisture Uptake/Sorption; 1.7.1 Classification of Hygroscopicity; 1.8 Polymorphism and Crystallinity; 1.8.1 Differential Scanning Calorimetry (DSC); 1.8.2 Thermogravimetric Analysis (TGA) | |
| 505 | 8 | |a 1.8.3 Powder X-ray Diffraction1.8.4 Crystallinity; 1.9 Stability; 1.9.1 Chemical Degradation in Solution; 1.9.2 Hydrolytic Degradation; 1.9.3 Stability in Solvents Used in Formulation and/or Manufacture; 1.9.4 Dimerization and Polymerisation; 1.9.5 Photostability; 1.9.6 pH-dependent Stability; 1.9.7 Oxidative Stability; 1.9.8 Stability-Compatibility; 1.10 Solid-state Physico-Technical Properties; Further Reading; References; Chapter 2 Hard Capsules in Modern Drug Delivery; 2.1 Introduction; 2.2 Hard Capsules-Types, Characteristics and Applications | |
| 505 | 8 | |a 2.2.1 Hard Capsules as a Pharmaceutical Excipient2.2.2 Hard Capsules for Special Applications; 2.3 Selection of Capsules in Formulation Development; 2.4 Hard Capsule Drug Delivery Addressing Pharmaceutical Needs; 2.4.1 Hard Capsule Powder Blend Formulation and Processing; 2.4.2 Highly Potent and Low-dose Drug Formulations; 2.4.3 Enhancing Bioavailability of Poorly Aqueous Soluble Drugs; 2.4.4 Physical Modification of the Drug Substance; 2.5 Targeted Drug Delivery; 2.5.1 Capsules with Solid Formulation; 2.5.2 Abuse Deterrent; 2.6 Manufacture of Commercial Hard Capsules Products | |
| 505 | 8 | |a 2.6.1 Powder and Granule Blends2.6.2 Multiparticulates and Mini-tablets; 2.6.3 Tablet Filling; 2.6.4 Liquid and Semi-solid Formulation; 2.6.5 Powder Micro-dosing; 2.7 Conclusions; Acknowledgements; References; Chapter 3 Soft Capsules; 3.1 Introduction; 3.2 Background; 3.3 Technology Strengths/Limitations; 3.4 Description; 3.5 Equipment and Facilities; 3.6 Shell Components; 3.7 Fill Formulation; 3.8 Product Development; 3.8.1 Fill Formulation Development Processes; 3.8.2 Shell Compatibility; 3.8.3 Prototype Manufacture; 3.8.4 Process Development; 3.9 Clinical Supply | |
| 505 | 8 | |a 3.10 Analytical Considerations3.11 Excipient Considerations; 3.11.1 Gelatin; 3.11.2 Plasticizers; 3.11.3 Water; 3.11.4 Colors, Opacifiers etc.; 3.11.5 Ingredient Specifications; 3.12 Packaging and Stability Considerations; 3.13 Manufacturing Process; 3.14 Key Process and Product Parameters; 3.14.1 In-process Testing; 3.14.2 Set up (Pre-start); 3.14.3 During Encapsulation; 3.14.4 During Drying; 3.14.5 Finished Product; 3.15 Recent Technology Advances; 3.15.1 Film Coating; 3.15.2 Non-gelatin Shell and Controlled Release Fill; 3.15.3 Vaginal Dosage Forms; 3.16 Trends in Patent Activity | |
| 520 | |a Pharmaceutical Formulation provides an up to date source of information for all who wish to understand the principles and practice of formulation in the drug industry. | ||
| 590 | |a Knovel |b ACADEMIC - Pharmaceuticals, Cosmetics & Toiletries | ||
| 650 | 0 | |a Drugs |x Dosage forms. | |
| 650 | 2 | |a Dosage Forms | |
| 650 | 2 | |a Drug Compounding | |
| 650 | 6 | |a Médicaments |x Formes pharmaceutiques. | |
| 650 | 7 | |a MEDICAL |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a Drugs |x Dosage forms |2 fast | |
| 650 | 7 | |a Health and Wellbeing. |2 ukslc | |
| 700 | 1 | |a Tovey, Geoffrey D., |e editor. | |
| 830 | 0 | |a RSC drug discovery series ; |v 64. | |
| 856 | 4 | 0 | |u https://appknovel.uam.elogim.com/kn/resources/kpPFTSTDF4/toc |z Texto completo |
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL5624957 | ||
| 938 | |a EBSCOhost |b EBSC |n 1867718 | ||
| 938 | |a YBP Library Services |b YANK |n 15913678 | ||
| 994 | |a 92 |b IZTAP | ||